47 results
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
to the conditions to the Offer (the date and time of such acceptance, the “Acceptance Time”), and subject to the satisfaction or waiver of the conditions … to any financing condition. The Offer is conditioned upon, among other things, the satisfaction of (i) the Minimum Condition (as described below
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
(“Rule 13e-3”) with respect to the Offer in the Schedule TO in the Offer Documents in satisfaction of their obligations under Rule 13e-3 (together … , but subject to the satisfaction or waiver of those conditions) shall have been satisfied or waived in accordance with this Agreement or (b) at such other
SC TO-C
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
Information about tender offer
6:08am
, including the satisfaction of closing conditions for the acquisition; the possibility that the transaction will not be completed; and the impact
SC TO-C
EX-99.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
Information about tender offer
6:08am
statements regarding the potential consummation of an acquisition, which involve a number of risks and uncertainties, including the satisfaction of closing
8-K
EX-1.1
9glnd7z
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
q5a 4j38f
3 Nov 22
Prospectus supplement for primary offering
4:42pm
424B3
r0w2o2bxj2e2dj4
6 May 21
Prospectus supplement
12:00am
8-K
EX-10.1
xowrh3o33kyqhxef xr
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am